Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3121-3126

  Poon, Ronnie Tung Ping ^a,b   Lau, Cecilia Pik Yuk ^a   Cheung, Siu Tim ^a   Yu, Wun Ching ^a   Fan, Sheung Tat ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD CLOTTING; CANCER STAGING; FEMALE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; BLOOD COAGULATION; BLOOD PLATELETS; CARCINOMA, HEPATOCELLULAR; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0037731710     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. (Bethesda), 82: 4-6, 1990.
2. Neufeld, G., Cohen, T., Gengrinovitch, S., and Poltorak, Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J., 13: 9-22, 1999.
3. Salven, P., Manpaa, H., Orpana, A., Alitalo, K., and Joensuu, H. Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin. Cancer Res., 3: 647-651, 1997.
4. Salven, P., Teerenhovi, L., and Joensuu, H. A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma. Blood, 90: 3167-3172, 1997.
5. Kumar, H., Heer, K., Lee, P. W., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J., and Monson, J. R. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin. Cancer Res., 4: 1279-1285, 1998.
6. Karayiannakis, A. J., Syrigos, K. N., Polychronidis, A., Zhar, A., Kouraklis, G., Simopoulos, C., and Karatzas, G. Circulating VEGF levels in the serum of gastric cancer patients: correlation with pathological variables, patient survival, and tumor surgery. Ann. Surg., 236: 37-42, 2002.
7. Poon, R. T., Fan, S. T., and Wong, J. Clinical implications of circulating angiogenic factors in cancer patients. J. Clin. Oncol., 19: 1207-1225, 200.
8. Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C., and Selby, P. J. Release of the angiogenic cytokine vascular endothelial growth (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br. J. Cancer. 77: 956-964, 1998.
9. Salgado, R., Vermeulen, P. B., Benoy, I., Weytjens, R., Huget, P., Van Marck, E., and Dirix, L. Y. Platelel number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients. Br. J. Cancer, 80: 892-897, 1999.
10. Salven, P., Orpana, A., and Joensuu, H. Leukocytes and platelets of patients with cancer contain high levels of vascular endothelial growth factor. Clin. Cancer Res., 5: 487-491, 1999.
11. George, M. L., Eccles, S. A., Tutton, M. G., Abulafi, A. M., and Swift, R. I. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging? Clin. Cancer Res., 6: 3147-3152, 2000.
12. Jelkmann, W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin. Chem., 47: 617-623, 2001.
13. Mohle, R., Green, D., Moore, M. A., Nachman, R. L., and Rafii, S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. USA. 94: 663-668, 1997.
14. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimaki, A., Heikinheimo, M., Joensuu, H., Alitalo, K., and Palotie, A. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemostasis, 80: 171-175, 1998.
15. Verheul, H. M., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J., and Pinedo, H. M. Platelet: transporter of vascular endothelial growth factor. Clin. Cancer Res., 3: 2187-2190, 1997.
16. Webb, N. J., Bottomley, M. J., Watson, C. J., and Brenchley, P. E. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease. Clin. Sci. (Lond.), 94: 395-404, 1998.
17. Benoy, I., Salgado, R., Colpaert, C., Weytjens, R., Vermeulen, P. B., and Dirix, L. Y. Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelel load in breast cancer patients. Clin. Breast Cancer, 2: 311-315, 2002.
18. Vermeulen, P. B., Salven, P., Benoy, I., Gasparini, G., and Dirix, L. Y. Blood platelets and serum VEGF in cancer patients. Br. J. Cancer, 79: 370-373, 1999.
19. Tanigawa, N., Lu, C., Mitsui, T., and Miura, S. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 26: 1216-1223, 1997.
20. Poon, R. T., Ng, I. O., Lau, C., Yu, W. C., Yang, Z. F., Fan, S. T., and Wong, J. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J. Clin. Oncol., 20: 1775-1785, 2002.
21. Li, X. M., Tang, Z. Y., Zhou, G., Lui, Y. K., and Ye, S. L. Significance of vascular endothelial growth factor mRNA expression in invasion and metastasis of hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 17: 13-17, 1998.
22. Ng, I. O., Poon, R. T., Lee, J. M., Fan, S. T., Ng, M., and Tso, W. K. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am. J. Clin. Pathol., 116: 838-845, 2001.
23. Li, X. M., Tang, Z. Y., Qin, L. X., Zhou, J., and Sun, H. C. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 18: 511-517, 1999.
24. Poon, R. T., Ng, I. O., Lau, C., Zhu, L. X., Yu, W. C., Lo, C. M., Fan, S. T., and Wong, J. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann. Surg. 233: 227-235, 2001.
25. AJCC. Liver including intrahepatic bite ducts. In: F. L. Greene, D. L. Page, I. D. Fleming, A. G. Fritz, C. M. Batch, D. G. Haller, and M. Morrow (eds.), American Joint Committee on Cancer Staging Manual, Ed 6. pp. 131-144 New York: Springer, 2002.
26. Linderholm, B., Grankvist, K., Wilking, N., Johansson, M., Tavelin, B., and Henriksson, R. Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. J. Clin. Oncol., 18: 1423-1431, 2000.
27. Bieche, I., Olivi, M., Champeme, M. H., Vidaud, D., Lidereau, R., and Vidaud, M. Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer. Int. J. Cancer. 78: 661-666, 1998.
28. -ΔΔCT method Methods. 25: 402-408, 2001.
29. Folkman, J. Clinical applications of reseach on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
30. Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., Yoshida, M., Ikeda, T., and Tominaga, T. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res., 2: 821-826, 1996.
31. Landriscina, M., Cassano, A., Ratto, C., Longo, R., Ippoliti, M., Palazzotti, B., Crucitti, F., and Barone, C. Quantitative analysis of basic fibroblast growth factor and vascular endothelial growth factor in human colorectal cancer. Br. J. Cancer, 78: 765-770, 1998.
32. Salgado, R., Benoy, I., Weytjens, R., Van Bockstaele, D., Van Marck, E., Huget, P., Hoylacrts, M., Vetmeulen, P., and Dirix, L. Y. Arteriovenous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer. Br. J. Cancer. 87: 1437-1444, 2002.
33. Handagama, P. J., George, J. N., Shumam M. A., McEver, R. P., and Bainton, D. F. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc. Natl. Acad. Sci. USA, 84: 861-865, 1987.
34. Trikha, M., and Nakada, M. T. Platelets and cancer: implications for antiangiogenic therapy. Semin. Thromh. Hemost., 28: 39-44, 2002.
35. Young, P. P., Hofling, A. A., and Sands, M. S. VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc. Natl. Acad. Sci. USA, 99: 11951-11956, 2002.
36. Verheut, H. M., Jorna, A. S., Hoekman, K., Broxterman, H. J., Gebbink, M. F., and Pinedo, H. M. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood, 96: 4216-4221, 2000.
37. Suzuki, H., Mori, M., Kawaguchi, C., Adachi, M., Miura, S., and Ishii, H. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma. Int. J. Oncol., 14: 1087-1090, 1999.
38. Werther, K., Christensen, I. J., and Nielsen, H. J. Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma. Br. J. Cancer, 86: 417-423, 2002.
39. Monreal, M., Femandez-Llamazares, J., Pinol, M., Julian, J. F., Broggi, M., Escola, D., and Abad, A. Platelet count and survival in patients with colorectal cancer - a preliminary study. Thromb. Haemostasis, 79: 916-918, 1998.